The effect of pre-COVID and post-COVID vaccination on long COVID: A systematic review and meta-analysis
Journal of Infection·
- DOI
- 10.1016/j.jinf.2024.106358
- PMID
- 39580033
- PMCID
- —
- OpenAlex
- W4404593346
- Study type
- Systematic review
- Publisher
- Elsevier BV
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The findings suggest that vaccination may serve as a measure to partially protect against long COVID, which affects millions and substantially reduces quality of life.
Structured evidence summary
Research question
The review examined whether vaccination before or after COVID-19 infection reduces the risk of long COVID, defined as symptoms persisting three months or beyond.
Study design
This systematic review and meta-analysis searched 13 databases through February 2024 and included 25 observational studies with over 14 million participants. No randomized controlled trials were identified. Risk of bias was assessed using ROBINS-I and certainty of evidence using GRADE.
Population and setting
The review analyzed data from individuals who received COVID-19 vaccination either before or after infection, with specified numbers of doses, across 25 observational studies.
Main findings
Two-dose pre-infection vaccination was associated with 24% reduced odds of long COVID and lower odds of four specific symptoms (fatigue, headache, loss of smell, muscle pain). One-dose post-infection vaccination was associated with 15% reduced odds of long COVID. Single-dose pre-infection vaccination showed no effect, while three-dose pre-infection and two-dose post-infection vaccination showed numerically reduced odds that did not reach statistical significance.
Public-health relevance
The findings suggest that vaccination may serve as a measure to partially protect against long COVID, which affects millions and substantially reduces quality of life.
Important limitations
All included studies were observational, with no randomized controlled trials available. This summary is limited to the supplied single-article abstract and metadata; the original paper is required for decision-grade interpretation including full assessment of heterogeneity, confounding, and GRADE certainty ratings.
GIDS interpretation
This systematic review is discoverable through Journal of Infection and provides synthesized evidence on vaccination and long COVID outcomes. It does not represent surveillance data and should be evaluated as secondary research synthesizing multiple primary studies.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 9 auditable classifier relationships to diseases, places, topics, and study design.